Niche NAD testing Opportunity to position NAD-related testing services and biomarker panels to support intracellular NAD analysis using dried blood spots, aligning with Jinfiniti’s recent test launch to expand test offerings and accessibility.

Precision medicine focus Sell companion diagnostic support, assay development partnerships, and data analytics services that enhance biomarker test accuracy and personalization, aligning with their mission to empower data-driven well-being.

Small team agility Target partnerships that scale with a lean organization; offer outsourced regulatory, clinical validation, and CRO-style support to accelerate product development without overburdening their headcount.

Growth through collaborations Leverage their funding range and growth trajectory by proposing co-development, licensing, or white-label opportunities with established genetics players to broaden market reach and credibility.

Digital enablement Provide digital infrastructure services, data integration, and privacy/compliance expertise to strengthen their online presence, patient data handling, and test result delivery capabilities as they expand.